www.nbcbayarea.com ·
most us doctors use this ai tool few patients know
Topic context
This topic has been covered 359701 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe article reports widespread adoption of an AI clinical decision support tool (OpenEvidence) among U.S. doctors. The commercial mechanism is weak: no direct pricing, supply chain, or margin impact is identified. The tool is free, so no revenue or cost channel for healthcare providers. Potential indirect effects on medical knowledge commoditization and reduced demand for traditional medical reference products are too speculative. No concrete company or product-level impact is described.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- 65% of U.S. doctors have adopted OpenEvidence over the past two years.
- In April 2026, OpenEvidence was used in nearly 27 million clinical encounters.
- OpenEvidence is free for healthcare providers.
- Over 80% of physicians reportedly use some form of AI in their practice.
